Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study-Reference-Cited by-同舟云学术

Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” study

Published:2022-05-05 Issue:1 Volume:56 Page:144-154
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Jachs Mathias¹²^ORCID,Schwarz Caroline³,Panzer Marlene⁴,Binter Teresa¹²,Aberle Stephan W.⁵,Hartl Lukas¹²,Dax Kristina⁶,Aigner Elmar⁷,Stättermayer Albert F.¹²,Munda Petra¹,Graziadei Ivo⁸,Holzmann Heidemarie⁵,Trauner Michael¹²,Zoller Heinz⁴^ORCID,Gschwantler Michael³,Mandorfer Mattias¹²^ORCID,Reiberger Thomas¹²^ORCID,Ferenci Peter¹^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Medicine III Medical University of Vienna Vienna Austria

2. Rare Liver Disease (RALID) Center of the European Reference Network for Rare Hepatological Diseases (ERN RARE‐LIVER) Medical University Vienna Vienna Austria

3. Department of Medicine 4 Klinik Ottakring Vienna Austria

4. Medical University of Innsbruck Innsbruck Austria

5. Center of Clinical Virology Medical University of Vienna Vienna Austria

6. Kepler Universitätsklinikum Linz Austria

7. SALK und Paracelsus Medical University Salzburg Austria

8. Department of Medicine Landeskrankenhaus Hall Austria

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology